(Q54355574)

28 May 2018

title

Induction of graft-versus-host disease after autologous bone marrow transplantation. (English)

1 reference

28 May 2018

1 reference

2

G B Vogelsang

1 reference

28 May 2018

author name string

R J Jones

1

1 reference

28 May 2018

A D Hess

3

1 reference

28 May 2018

E R Farmer

4

1 reference

28 May 2018

R B Mann

5

1 reference

28 May 2018

R B Geller

6

1 reference

28 May 2018

S Piantadosi

7

1 reference

28 May 2018

G W Santos

8

1 reference

28 May 2018

language of work or name

English

0 references

publication date

1 April 1989

1 reference

28 May 2018

published in

The Lancet

1 reference

28 May 2018

volume

1

1 reference

28 May 2018

issue

8641

1 reference

28 May 2018

page(s)

754-757

1 reference

28 May 2018

Comparison of autologous and allogeneic bone marrow transplantation for treatment of high-risk refractory acute lymphoblastic leukemia

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2889%2992575-0

7 January 2021

How does bone-marrow transplantation cure leukaemia?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2889%2992575-0

7 January 2021

Acute graft-vs-host disease. Development following autologous and syngeneic bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2889%2992575-0

7 January 2021

Development of graft-vs.-host disease-like syndrome in cyclosporine-treated rats after syngeneic bone marrow transplantation. I. Development of cytotoxic T lymphocytes with apparent polyclonal anti-Ia specificity, including autoreactivity

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2889%2992575-0

7 January 2021

High-dose therapy and autologous bone marrow transplantation after failure of conventional chemotherapy in adults with intermediate-grade or high-grade non-Hodgkin's lymphoma.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2889%2992575-0

7 January 2021

Myasthenia gravis after bone-marrow transplantation. Evidence for a donor origin

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2889%2992575-0

7 January 2021

Thymus and autoimmunity. Transplantation of the thymus from cyclosporin A-treated mice causes organ-specific autoimmune disease in athymic nude mice

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2889%2992575-0

7 January 2021

Effects of cyclosporine A on T cell development and clonal deletion

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2889%2992575-0

7 January 2021

Methotrexate and cyclosporine compared with cyclosporine alone for prophylaxis of acute graft versus host disease after marrow transplantation for leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2889%2992575-0

7 January 2021

T cell depletion with CAMPATH-1 in allogeneic bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2889%2992575-0

7 January 2021

10.1016/S0140-6736(89)92575-0

Identifiers

DOI

1 reference

28 May 2018

1 reference

28 May 2018